Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation

A Multicenter, Open-Label, Prospective Study of Cannula Injection of Restylane Lyft With Lidocaine for Cheek Augmentation and the Correction of Age Related Midface Contour Deficiencies

This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.

Primary Inclusion Criteria:

• Subjects willing to comply with the requirements of the study and providing a signed written informed consent.
• Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
• Mild to Substantial Midface Volume Loss

Primary Exclusion Criteria:

• Allergy or hypersensitivity to any injectable hyaluronic acid gel or to gram positive bacterial proteins
• Allergy or hypersensitivity to lidocaine or other amide-type anaesthetics, or topical anaesthetics or nerve blocking agents
• Undergone prior surgery to midface